missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ Coagulation Factor III/Tissue Factor Antibody (Chugai patent anti-TF) - Humanized, IgG4SP, Novus Biologicals™

Human Monoclonal Antibody

Brand:  Novus Biologicals™ NBP3-28586-100ug

 View more versions of this product

Product Code. 30048200

  • £257.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Coagulation Factor III/Tissue Factor Monoclonal antibody specifically detects Coagulation Factor III/Tissue Factor in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Coagulation Factor III/Tissue Factor
Monoclonal
Unconjugated
P13726
Human
Protein A purified
RUO
Primary
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Store at -20°C in powder form. Store at -80°C once reconstituted.
IgG4
Flow Cytometry, ELISA, Functional Assay
Chugai patent anti-TF
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
CD142, CD142 antigen, Coagulation factor III, coagulation factor III (thromboplastin, tissue factor), FLJ17960, TF, TFA, Thromboplastin, tissue factor
F3/ Factor III/ Tissue Factor/ CD142
100 μg
Cancer
2152
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.